Revenue Cycle Management in AI Search: The Biggest AI Visibility Problems and How We'd Fix Them

Mark HuntleyBy Mark HuntleyFounder and CEO
21 minutes read

Key Takeaways

  • athenahealth led total mentions and recommendations, but R1 RCM and Optum earned more first-place placements.
  • The top four companies accounted for most of the visibility, while the remaining six had much lower reach.
  • Several recorded conflicts involved ownership, leadership, and market-share claims that should be checked against primary sources.
  • The recommended next steps are to verify disputed facts, review owned pages, and assess third-party sources before measuring again.

Companies covered: Optum, R1 RCM, Waystar, TruBridge, AGS Health, athenahealth, Experian Health, GeBBS Healthcare, Conifer Health Solutions, Ensemble Health Partners

Answer Capsule

The November 2026 Revenue Cycle Management benchmark compares 10 companies across 371 AI answers that met its inclusion rules. athenahealth recorded 243 mentions and 162 recommendations (43.67% of the answers). Being mentioned means appearing in an answer; being recommended means receiving an affirmative endorsement.

We examine each company, establish the current research baseline, and set out a five-step plan for improving the information AI systems can draw on. The work starts with measuring visibility and checking conflicting claims, then moves to company pages, relevant publishers and buyer questions. The cited pages need review before any correction request, and the research does not establish what caused recommendation differences or promise future gains.

Executive industry diagnosis

Questions This Section Answers

  • What does the Revenue Cycle Management benchmark show about mentions, recommendations and placement?

Rank

Company

Mentions

Mention rate

Recommendations

Recommendation rate

Top 3

Top 3 rate

#1

#1 rate

1

athenahealth

243

65.50%

162

43.67%

97

26.15%

26

7.01%

2

R1 RCM

218

58.76%

154

41.51%

105

28.30%

58

15.63%

3

Optum

218

58.76%

137

36.93%

97

26.15%

40

10.78%

4

Waystar

180

48.52%

122

32.88%

72

19.41%

32

8.63%

5

Ensemble Health Partners

76

20.49%

54

14.56%

27

7.28%

2

0.54%

6

AGS Health

66

17.79%

52

14.02%

11

2.96%

5

1.35%

7

Experian Health

67

18.06%

46

12.40%

10

2.70%

0

0.00%

8

Conifer Health Solutions

78

21.02%

45

12.13%

19

5.12%

0

0.00%

9

GeBBS Healthcare

64

17.25%

40

10.78%

17

4.58%

6

1.62%

10

TruBridge

35

9.43%

17

4.58%

7

1.89%

3

0.81%

The peer set splits into two tiers. athenahealth, R1 RCM, Optum and Waystar appear in roughly half or more of the answers and carry most of the endorsements, while the remaining six companies cluster at much lower reach. For a buyer, that means the shortlist conversation is largely settled before the smaller vendors enter it.

Placement adds a second distinction. R1 RCM and Optum convert their visibility into first-place positions far more often than athenahealth, which leads on total mentions but not on top billing. Reach and position are separate assets, and a company can hold one without the other.

For the agency, the practical implication is that work should be sequenced by tier. The leading four warrant fact-checking and page review to protect existing standing; the challengers need clearer, verifiable positioning before any placement gains are realistic.

What changed since last month

Questions This Section Answers

  • What changed across the usable monthly Revenue Cycle Management snapshots?

Company

Nov 2026

athenahealth

162 / 371 (43.67%)

R1 RCM

154 / 371 (41.51%)

Optum

137 / 371 (36.93%)

Waystar

122 / 371 (32.88%)

Ensemble Health Partners

54 / 371 (14.56%)

AGS Health

52 / 371 (14.02%)

Experian Health

46 / 371 (12.40%)

Conifer Health Solutions

45 / 371 (12.13%)

GeBBS Healthcare

40 / 371 (10.78%)

TruBridge

17 / 371 (4.58%)

Only months with verified results are shown. Monthly sample coverage is listed in Methodology.

This edition is a new baseline rather than a continuation. Earlier editions used a narrower question set, so the current figures cannot be read as improvement or decline against them. The archive stays as a record, not a trend line.

What the month shows is a single selected sample: a fixed set of answers, each counted once per company. Differences between companies within this sample are meaningful; differences against prior months are not yet comparable. Future editions run on the same screening scope will be the first fair comparison point.

AI recommendation trend

Observed recommendation rate (%), Nov 2026

  • athenahealthno change
    Nov 202643.67%
  • R1 RCMno change
    Nov 202641.51%
  • Optumno change
    Nov 202636.93%
  • Waystarno change
    Nov 202632.88%
  • Ensemble Health Partnersno change
    Nov 202614.56%
  • AGS Healthno change
    Nov 202614.02%
  • Experian Healthno change
    Nov 202612.40%
  • Conifer Health Solutionsno change
    Nov 202612.13%
  • GeBBS Healthcareno change
    Nov 202610.78%
  • TruBridgeno change
    Nov 20264.58%

Separate selected monthly samples. Missing points are unavailable, not zero. Provider/prompt equivalence is unverified; rate movement does not demonstrate causation.

Company-by-company findings

Optum

Questions This Section Answers

  • What measured visibility pattern and review priority does Optum have in Revenue Cycle Management?

Optum recorded 218 mentions (58.76%) and 137 recommendations (36.93%) across 371 answers included in the benchmark. Top 3 placements numbered 97; first-place recommendations numbered 40. Framing among its mentions was 146 positive, 70 neutral and 2 negative.

This edition establishes a broader research baseline. Earlier editions used a narrower set of questions, so their figures are not treated as a performance trend.

AI answers contained 6 conflicting claims about Optum: 0 critical, 0 high, 5 medium, 1 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

Review topic

Severity

Recorded AI claim A

Recorded AI claim B

CEO of Optum Bank

medium

Dhivya Suryadevara (CEO of Optum Financial)

Gavin Payne (President/CEO of Optum Bank)

ownership of CoverMyMeds

medium

CoverMyMeds owned by Change Healthcare/Optum

CoverMyMeds owned by McKesson

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

Question observed in the research

Benchmark answers to this question

Company mentions

Company recommendations

What are the best RCM companies?

6

5

5

What are the top 10 healthcare revenue cycle management companies in the US?

5

5

5

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://business.optum.com/en/operations-technology/revenue-cycle-management.html.

Selected third-party review candidate: https://beckershospitalreview.com/healthcare-information-technology/optum-division-appoints-2nd-new-ceo-in-four-months/.

Optum's reach is strong and its first-place share is among the highest in the set, so its standing rests on position as much as presence. The recorded conflicts concern leadership and ownership details, which are exactly the facts a buyer may check. We would propose a scoped fact-check against current primary sources before any correction is considered, then a page brief for the owned RCM page.

R1 RCM

Questions This Section Answers

  • What measured visibility pattern and review priority does R1 RCM have in Revenue Cycle Management?

R1 RCM recorded 218 mentions (58.76%) and 154 recommendations (41.51%) across 371 answers included in the benchmark. Top 3 placements numbered 105; first-place recommendations numbered 58. Framing among its mentions was 162 positive, 56 neutral and 0 negative.

This edition establishes a broader research baseline. Earlier editions used a narrower set of questions, so their figures are not treated as a performance trend.

AI answers contained 0 conflicting claims about R1 RCM: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

Question observed in the research

Benchmark answers to this question

Company mentions

Company recommendations

What are the best RCM companies?

6

6

6

Which company is best in medical billing?

6

6

6

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://r1rcm.com/about.

Selected third-party review candidate: https://keragon.com/blog/revenue-cycle-management-companies.

R1 RCM pairs broad visibility with the strongest first-place showing in the peer set, and its mentions carried no negative framing. That combination makes it a benchmark others are measured against rather than a repair case. The proposed work is protective: a page brief for the owned about page and a source review of the third-party list, both conditional on verifying current contents.

Waystar

Questions This Section Answers

  • What measured visibility pattern and review priority does Waystar have in Revenue Cycle Management?

Waystar recorded 180 mentions (48.52%) and 122 recommendations (32.88%) across 371 answers included in the benchmark. Top 3 placements numbered 72; first-place recommendations numbered 32. Framing among its mentions was 129 positive, 51 neutral and 0 negative.

This edition establishes a broader research baseline. Earlier editions used a narrower set of questions, so their figures are not treated as a performance trend.

AI answers contained 0 conflicting claims about Waystar: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

Question observed in the research

Benchmark answers to this question

Company mentions

Company recommendations

What is the best clearinghouse for medical billing?

5

5

5

Which is the best RCM?

5

5

5

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://waystar.com/.

Selected third-party review candidate: https://data.landbase.com/technology/waystar/.

Waystar sits in the leading tier with solid reach and a meaningful share of first-place positions, and no conflicting claims were recorded for it. The useful work here is reinforcement rather than repair. We would propose a page brief for the owned site and a review of the third-party profile, confirming facts before any request is drafted.

TruBridge

Questions This Section Answers

  • What measured visibility pattern and review priority does TruBridge have in Revenue Cycle Management?

TruBridge recorded 35 mentions (9.43%) and 17 recommendations (4.58%) across 371 answers included in the benchmark. Top 3 placements numbered 7; first-place recommendations numbered 3. Framing among its mentions was 19 positive, 16 neutral and 0 negative.

This edition establishes a broader research baseline. Earlier editions used a narrower set of questions, so their figures are not treated as a performance trend.

AI answers contained 3 conflicting claims about TruBridge: 0 critical, 0 high, 3 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

Review topic

Severity

Recorded AI claim A

Recorded AI claim B

hospital market share

medium

4.3%

7.6%

US acute-care hospital EMR market share

medium

~7.6%

~4.3%

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

Question observed in the research

Benchmark answers to this question

Company mentions

Company recommendations

What are the top 10 RCM companies in the US?

5

1

1

What are the top RCM companies?

5

1

1

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://trubridge.com/resources/what-is-a-clearinghouse-in-medical-billing/.

Selected third-party review candidate: https://definitivehc.com/blog/most-common-inpatient-ehr-systems.

TruBridge has the smallest footprint in the peer set, and its recorded conflicts concern hospital and EMR market-share figures. Those numbers are the kind a buyer could repeat, so they carry outsized risk relative to the company's visibility. We would propose a fact-check of the share claims against primary sources first, with a page brief for the clearinghouse resource page to follow only if the facts hold.

AGS Health

Questions This Section Answers

  • What measured visibility pattern and review priority does AGS Health have in Revenue Cycle Management?

AGS Health recorded 66 mentions (17.79%) and 52 recommendations (14.02%) across 371 answers included in the benchmark. Top 3 placements numbered 11; first-place recommendations numbered 5. Framing among its mentions was 56 positive, 10 neutral and 0 negative.

This edition establishes a broader research baseline. Earlier editions used a narrower set of questions, so their figures are not treated as a performance trend.

AI answers contained 0 conflicting claims about AGS Health: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

Question observed in the research

Benchmark answers to this question

Company mentions

Company recommendations

What are the top 10 healthcare revenue cycle management companies in the US?

5

5

5

What are the major RCM companies in healthcare?

5

3

3

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://agshealth.com/ai-platform/computer-assisted-coding/.

Selected third-party review candidate: https://definitivehc.com/resources/healthcare-insights/largest-rcm-vendors.

AGS Health shows a notable pattern: most of its mentions also carried a recommendation, yet first-place positions are rare. Reach and endorsement are present; top billing is not. That gap is about position, not credibility. We would propose a page brief for the coding platform page and a review of the third-party vendor list, both starting from verified current contents.

athenahealth

Questions This Section Answers

  • What measured visibility pattern and review priority does athenahealth have in Revenue Cycle Management?

athenahealth recorded 243 mentions (65.50%) and 162 recommendations (43.67%) across 371 answers included in the benchmark. Top 3 placements numbered 97; first-place recommendations numbered 26. Framing among its mentions was 173 positive, 70 neutral and 0 negative.

This edition establishes a broader research baseline. Earlier editions used a narrower set of questions, so their figures are not treated as a performance trend.

AI answers contained 6 conflicting claims about athenahealth: 0 critical, 0 high, 4 medium, 2 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

Review topic

Severity

Recorded AI claim A

Recorded AI claim B

ownership / corporate parent

medium

independent company

part of Veradigm

ownership / corporate parent

medium

independent company

part of Veradigm

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

Question observed in the research

Benchmark answers to this question

Company mentions

Company recommendations

Which company is best in medical billing?

6

6

6

What are the best RCM companies?

6

5

5

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://athenahealth.com/.

Selected third-party review candidate: https://keragon.com/blog/revenue-cycle-management-companies.

athenahealth leads the peer set on total mentions and recommendations, though its first-place share trails R1 RCM and Optum. The recorded conflicts concern its ownership status, a fact a buyer could easily repeat and get wrong. We would propose a fact-check of the corporate-parent claims against primary sources, paired with a page brief for the owned homepage.

Experian Health

Questions This Section Answers

  • What measured visibility pattern and review priority does Experian Health have in Revenue Cycle Management?

Experian Health recorded 67 mentions (18.06%) and 46 recommendations (12.40%) across 371 answers included in the benchmark. Top 3 placements numbered 10; first-place recommendations numbered 0. Framing among its mentions was 49 positive, 18 neutral and 0 negative.

This edition establishes a broader research baseline. Earlier editions used a narrower set of questions, so their figures are not treated as a performance trend.

AI answers contained 0 conflicting claims about Experian Health: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

Question observed in the research

Benchmark answers to this question

Company mentions

Company recommendations

What are the best RCM companies?

6

3

2

What are revenue cycle management tools?

2

2

2

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected third-party review candidate: https://definitivehc.com/resources/healthcare-insights/largest-rcm-vendors.

Experian Health appears in a meaningful share of answers and most of those mentions carried a recommendation, but it recorded no first-place positions in this sample. Endorsement reach is real; top billing is absent. We would propose a page brief tied to the observed revenue cycle tools question and a review of the third-party vendor list, verifying contents before any request.

GeBBS Healthcare

Questions This Section Answers

  • What measured visibility pattern and review priority does GeBBS Healthcare have in Revenue Cycle Management?

GeBBS Healthcare recorded 64 mentions (17.25%) and 40 recommendations (10.78%) across 371 answers included in the benchmark. Top 3 placements numbered 17; first-place recommendations numbered 6. Framing among its mentions was 45 positive, 19 neutral and 0 negative.

This edition establishes a broader research baseline. Earlier editions used a narrower set of questions, so their figures are not treated as a performance trend.

AI answers contained 0 conflicting claims about GeBBS Healthcare: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

Question observed in the research

Benchmark answers to this question

Company mentions

Company recommendations

What are the top 10 healthcare revenue cycle management companies in the US?

5

4

4

What are the major RCM companies in healthcare?

5

4

3

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://gebbs.com/revenue-cycle-management/medical-coding/remote-medical-coding/.

Selected third-party review candidate: https://helpware.com/blog/healthcare-rcm-companies.

GeBBS Healthcare holds a mid-tier position with steady endorsement reach and no recorded conflicts. Its appearances cluster around list-style questions, which suggests the work is about being described accurately in roundups rather than repairing errors. We would propose a page brief for the remote coding page and a source review of the roundup that covers it.

Conifer Health Solutions

Questions This Section Answers

  • What measured visibility pattern and review priority does Conifer Health Solutions have in Revenue Cycle Management?

Conifer Health Solutions recorded 78 mentions (21.02%) and 45 recommendations (12.13%) across 371 answers included in the benchmark. Top 3 placements numbered 19; first-place recommendations numbered 0. Framing among its mentions was 49 positive, 29 neutral and 0 negative.

This edition establishes a broader research baseline. Earlier editions used a narrower set of questions, so their figures are not treated as a performance trend.

AI answers contained 0 conflicting claims about Conifer Health Solutions: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

Question observed in the research

Benchmark answers to this question

Company mentions

Company recommendations

What are the top 10 RCM companies in the US?

5

4

4

What are the top 10 healthcare revenue cycle management companies in the US?

5

4

4

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://coniferhealth.com/solutions/revenue-cycle-outsourcing/.

Selected third-party review candidate: https://definitivehc.com/resources/healthcare-insights/largest-rcm-vendors.

Conifer Health Solutions has respectable reach and a solid recommendation share, but no first-place positions were recorded. It is consistently present without leading. The proposed work is a page brief for the revenue cycle outsourcing page and a review of the vendor list where it appears, both conditional on confirming current page contents.

Ensemble Health Partners

Questions This Section Answers

  • What measured visibility pattern and review priority does Ensemble Health Partners have in Revenue Cycle Management?

Ensemble Health Partners recorded 76 mentions (20.49%) and 54 recommendations (14.56%) across 371 answers included in the benchmark. Top 3 placements numbered 27; first-place recommendations numbered 2. Framing among its mentions was 59 positive, 17 neutral and 0 negative.

This edition establishes a broader research baseline. Earlier editions used a narrower set of questions, so their figures are not treated as a performance trend.

AI answers contained 0 conflicting claims about Ensemble Health Partners: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

Question observed in the research

Benchmark answers to this question

Company mentions

Company recommendations

What are the top 10 healthcare revenue cycle management companies in the US?

5

5

5

What are the top RCM companies?

5

4

4

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://ensemblehp.com/.

Selected third-party review candidate: https://helpware.com/blog/healthcare-rcm-companies.

Ensemble Health Partners shows strong recommendation reach relative to its first-place count, a pattern shared with several challengers. It is endorsed often but rarely named first. We would propose a page brief for the owned homepage and a review of the third-party roundup, using verified facts to sharpen how the company is described in list contexts.

/ Take the next step

Want to Understand Your AI Citation Footprint?

We start every engagement with a full audit of how AI systems reference your brand today.

Measurable, Repeatable Programme

Build a durable foundation of credible citations that compounds over time and continues to influence AI answers as new queries emerge

Citation Architecture Review

Identify which high-authority community sources are and aren't working in your favour across AI platforms.

AI Visibility Audit

Understand exactly how LLMs are referencing your brand today and which sources are shaping those answers.

The CiteWorks five-step improvement plan

Step 1. Establish the baseline

Questions This Section Answers

  • What should the agency deliver when it works to establish the baseline for Revenue Cycle Management?

Build a scorecard that records each company's mentions, recommendations and placements exactly as measured, with the question set and screening rules attached. The point is a fixed reference others can audit. Document the scope now so the next edition can be compared honestly rather than reconstructed after the fact.

Step 2. Verify disputed facts

Questions This Section Answers

  • What should the agency deliver when it works to verify disputed facts for Revenue Cycle Management?

AI answers contained 15 conflicting claims across 3 companies. Another 0 possible conflicts were excluded because their company matches were uncertain. The conflicting claims need fact-checking before any corrections are proposed.

Work through the recorded conflicts company by company, starting with the ownership and leadership claims and the market-share figures. Each needs a current primary source before anyone decides whether a correction is warranted. Ambiguous company matches stay out of the queue, and a resolved conflict may simply confirm the answer was right.

Step 3. Review owned pages

Questions This Section Answers

  • What should the agency deliver when it works to review owned pages for Revenue Cycle Management?

Turn the supplied owned-page candidates into briefs: what the page should establish, which facts need confirming, and what a buyer would want answered. Briefs are proposals, not edits. No change should be drafted until the current page contents and the underlying facts have been checked.

Step 4. Review third-party sources

Questions This Section Answers

  • What should the agency deliver when it works to review third-party sources for Revenue Cycle Management?

For each third-party publisher, confirm what the page currently says before preparing any request. Citation appearances show where answers drew on sources; they do not show that a source shaped a recommendation. Requests should be evidence-backed and framed as corrections of verified facts, not as placement asks.

Step 5. Address buyer questions and measure again

Questions This Section Answers

  • What should the agency deliver when it works to address buyer questions and measure again for Revenue Cycle Management?

Draft content around the buyer questions actually observed, answering them plainly and with verifiable detail. Then measure again on the same scope. Keep delivered work in a separate record from answer outcomes, so completed briefs are never presented as proof that visibility improved.

Third-party authority and citation opportunities

Questions This Section Answers

  • Which cited publisher pages support targeted source review in Revenue Cycle Management?

Publisher page selected for review

Citation appearances in all captured answers

Companies covered by the page selection

https://definitivehc.com/resources/healthcare-insights/largest-rcm-vendors

30

AGS Health, Experian Health, Conifer Health Solutions, Ensemble Health Partners

https://helpware.com/blog/healthcare-rcm-companies

18

AGS Health, GeBBS Healthcare, Conifer Health Solutions, Ensemble Health Partners

https://keragon.com/blog/revenue-cycle-management-companies

61

R1 RCM, athenahealth

https://beckershospitalreview.com/finance/revenue-cycle-management/385-revenue-cycle-management-companies-to-know-2026/

56

R1 RCM, athenahealth

https://definitivehc.com/blog/most-common-inpatient-ehr-systems

27

TruBridge

https://ehrinpractice.com/largest-ehr-vendors.html

16

TruBridge

https://rapidclaims.ai/blogs/top-healthcare-revenue-cycle-management-companies-usa

14

GeBBS Healthcare

https://experian.com/healthcare/solutions/revenue-cycle-management-solution

4

Experian Health

https://data.landbase.com/technology/waystar/

2

Waystar

https://beckershospitalreview.com/healthcare-information-technology/optum-division-appoints-2nd-new-ceo-in-four-months/

1

Optum

These pages are candidates for review, not confirmed errors. Citation appearances are counted across the captured answers and are not added again for each company.

The publisher list should be prioritized by how many companies a page covers and how often it appeared in captured answers, not by any single company's interest. The large vendor roundups reach several companies at once, which makes them efficient review targets; the narrower pages matter mainly to the company they cover.

Every page needs a current-content check before any request. A citation tells us an answer drew on a source, not that the source influenced a recommendation or that it contains an error. Requests should follow verification, and a page that turns out to be accurate needs no approach at all.

What we'd prioritize first

Period

Deliverable

Completion criterion

Days 1–30

Baseline scorecard, scoped fact-review register and page/source shortlist

Each record has an owner, evidence requirement and review status

Days 31–60

Approved page briefs and justified publisher requests

Separate confirmed edits, no-change decisions, requests and responses

Days 61–90

Buyer-content briefs and a fresh scorecard

Record work completed separately from measured answer outcomes and comparability limits

Start with the baseline scorecard and the fact-review register, because the ownership, leadership and market-share conflicts are the items most likely to mislead a buyer and the easiest to resolve with primary sources. Page and source shortlists follow from that register rather than running ahead of it.

In the middle period, convert verified findings into page briefs and justified publisher requests, recording confirmed edits, no-change decisions and responses separately. Later, draft buyer-question content and run a fresh scorecard on the same scope, keeping completed work distinct from measured outcomes.

Methodology and conclusion

Questions This Section Answers

  • What do the Revenue Cycle Management sample and source-review limits allow us to conclude?

This edition includes all relevant captured answers, including buyer questions reserved from the limited email report. Every captured answer was screened and every relevant answer was included in the figures. Mentions require the company to be identified in the answer; incidental uses of its name as an ordinary word are not counted. Mentions require the company to be identified in the answer; incidental uses of its name as an ordinary word are not counted. Ahrefs queries return a bounded brand-query sample, not every AI answer available.

This report covers 2026-11. The exact dates when the original AI answers were collected have not been verified. The visibility rates use 371 answers that met the benchmark's inclusion rules. A company is recommended only when the answer both endorses it and uses positive wording. Top 3 and first-place counts are part of those recommendations, not extra recommendations.

An answer can mention or recommend several companies, so company counts cannot be added to find the number of distinct answers. The net sentiment score is positive minus negative mentions, divided by all company mentions; it describes answer wording, not customer satisfaction.

The wider citation analysis covers 800 captured answers and 4872 appearances of cited URLs. Citation appearances across all captured answers differ from the number of benchmark answers citing a page and the number that also recommend a company. The current contents of cited pages and disputed company claims still need independent verification.

Monthly sample coverage:

Reporting month

Answers included

AI services covered

Services

Nov 2026

371

6

ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity

July 2026 measured a different set of companies, so it is excluded from this comparison. August 2026 measured a different set of companies, so it is excluded from this comparison. Earlier editions (September 2026 and October 2026) used a narrower set of questions. This edition includes all captured answers screened as relevant and establishes a broader baseline. Earlier figures remain in the archive; they are not used to claim a change in performance.

Future editions using the same screening scope can be compared against this baseline.

Read the figures as a description of what these answers said in this sample, not as a market share or a customer verdict. Mentions, recommendations and placements are nested measures, and an answer can cover several companies, so counts are not additive. The net sentiment score describes wording, not satisfaction.

The citation analysis is broader than the benchmark and does not establish influence. Current page contents and disputed claims still need independent verification. The useful next step is to hold the scope steady, resolve the recorded conflicts, and compare the next edition against this baseline without promising that any single action will move the numbers.

This analysis is based on the source benchmark: Revenue Cycle Management AI visibility benchmark

/ Learn More

Understanding AI search visibility.

AI search experiences create answers by pulling information from many places online and summarizing it into a single response.

What Is AI Citation Intelligence?
AI citation intelligence is the process of measuring where AI platforms source their information and how frequently a brand is mentioned or referenced in AI-generated responses. Because LLMs synthesize across multiple sources, the sites and brands that appear repeatedly tend to influence how a topic or company is framed. This practice focuses on identifying which sources shape AI outputs and tracking brand visibility across different AI systems.
What Is Citation Architecture?
Citation architecture describes the set of sources that consistently inform how AI systems talk about a brand, product, or topic. LLMs draw from websites, articles, forums, and public discussion, and the sources they rely on most often become the backbone of their answers. Building strong citation architecture means ensuring that accurate, credible, high authority sources are the ones most likely to shape the way AI tools summarize and recommend a brand.
What Is Generative Engine Optimization?
Generative engine optimization (GEO) is the practice of improving the chances that AI systems use and cite your brand or content when generating answers. While traditional SEO is centered on ranking pages in search results, GEO focuses on how LLMs retrieve, interpret, and combine information when responding to a question. The objective is to strengthen the content and sources AI systems rely on, so your brand is treated as a trusted reference in AI responses.
What Is AI Share of Voice?
AI share of voice tracks how often a brand appears in AI-generated answers compared with competitors in the same category. It reflects visibility across AI platforms such as ChatGPT, Gemini, Claude, and Perplexity. Monitoring AI share of voice helps organizations see whether AI systems consistently include and recommend their brand for key queries or whether competitor brands are showing up more often.

About The Author

Mark Huntley

Mark Huntley

Founder and CEO

Mark Huntley, J.D. is founder of CiteWorks Studio, a strategic advisory focused on visibility, authority, and recommendation presence in AI-shaped search environments. His work centers on embedding-level GEO, vector optimization, and cosine gap engineering — helping brands align their digital presence with the retrieval systems that increasingly shape discovery, interpretation, and choice.

Archived editions

Browse earlier published research snapshots for this article. The latest edition remains at the current URL.

VIEW ALL CASE STUDIESREQUEST AN AI VISIBILITY AUDIT